Micro Cap
Drug Manufacturers - General
Stocks Ranked by
Market Capitalization

Major, global pharmaceutical manufacturers offering a broad and diverse line of drug and healthcare products; industry leaders that have made a significant commitment to the research and development of a long pipeline of drugs.

#	Name	Market cap	Price	Price change %
1	CYBN 1 Cybin CYBN $181M	$181M	$7.64	0.39%
2	CURX 2 Curanex Pharmaceuticals Inc Common Stock CURX $144M	$144M	$5.19	11.4%
3	3 Protalix BioTherapeutics PLX $128M	$128M	$1.55	3.13%
4	4 Scilex Holding SCLX $125M	$125M	$18.23	1.17%
5	5 CEL-SCI Corp CVM $89.7M	$89.7M	$9.31	28.6%
6	6 Armata Pharmaceuticals ARMP $88.4M	$88.4M	$2.56	4.92%
7	OSTX 7 OS Therapies Incorporated OSTX $79.7M	$79.7M	$2.26	9.6%
8	8 Xtant Medical Holdings XTNT $79.7M	$79.7M	$0.6300	3.06%
9	9 Innovator US Equity Ultra Buffer ETF November UNOV $73.2M	$73.2M	$37.07	0.14%
10	NSRX 10 Nasus Pharma Ltd. NSRX $73M	$73M	$8.05	0.12%
11	PTHS 11 Pelthos Therapeutics Inc. PTHS $72.2M	$72.2M	$22.99	3.08%
12	12 Actinium Pharmaceuticals ATNM $54.9M	$54.9M	$1.74	1.14%
13	13 MAIA Biotechnology MAIA $54.4M	$54.4M	$1.52	7.88%
14	14 Serina Therapeutics SER $51.2M	$51.2M	$5.13	2.81%
15	15 Harrow 11.875% Senior Notes due 2027 HROWM $41.9M	$41.9M	$26.03	0.23%
16	16 IGC Pharma IGC $38.6M	$38.6M	$0.4249	5.87%
17	MDCX 17 Medicus Pharma Ltd. Common Stock MDCX $36.2M	$36.2M	$2	1.48%
18	18 AB Corporate Bond ETF EYEG $28.7M	$28.7M	$35.85	–
19	KAPA 19 Kairos Pharma, Ltd. KAPA $26.1M	$26.1M	$1.26	6.78%
20	20 MIRA Pharmaceuticals MIRA $26.1M	$26.1M	$1.40	2.19%
21	APUS 21 Apimeds Pharmaceuticals US, Inc. APUS $23.8M	$23.8M	$1.86	1.59%
22	22 NanoViricides NNVC $22.8M	$22.8M	$1.42	0%
23	CPSR 23 Calamos S&P 500 Structured Alt Protection ETF - March CPSR $22.2M	$22.2M	$24.64	0.04%
24	24 BiomX PHGE $14.5M	$14.5M	$0.5481	0.85%
25	25 Matinas BioPharma MTNB $11M	$11M	$2.04	3.03%